The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTNT.L Regulatory News (TNT)

  • There is currently no data for TNT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic investment under current funding round

10 Mar 2023 10:30

RNS Number : 5968S
Tintra PLC
10 March 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

 

10 March 2023

TINTRA PLC

 ("Tintra", the "Group" or the "Company")

 

Strategic investment under current funding round,

update on the funding round

and

Total Voting Rights

 

The board of directors of Tintra (the "Board") is pleased to confirm that, further to the Company's announcement of 30 November 2022 (the "November 2022 Announcement"), it has entered into a new subscription agreement (under the current funding round) for US$2,000,000 (the "Subscription"). 

 

Background

 

As announced by the Company on 10 January 2022, the Company had previously agreed with a strategic Gulf-based investor for them to subscribe for new ordinary shares in the Company, conditional on the Group exiting its involvement in the lottery administration business (the "Original Subscription"). The Original Subscription expired following the passing of the long-stop date of 1 April 2022. Since then, and as indicated in the November 2022 Announcement, the Board has presented to certain High Net Worth Investors and Family Offices, including the strategic Gulf-based investor, and as a result the Company is pleased to confirm a new investment by the strategic Gulf-based investor.

 

Subscription details

 

The Subscription will be made through a new special purpose vehicle (the "SPV") which is being established by the Gulf-based investor for the purpose of making the investment. The Subscription has no conditionality, however based on earlier funding rounds taking longer to close than anticipated, the funds due under the Subscription are, under the agreement entered into between the Company and the investor, contracted to be received within 45 days to enable the establishment of the SPV.

 

The Subscription is for 141,483 new ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares"), priced at 1178 pence per Ordinary Share, at an exchange rate of £1.00:$1.20 (the "Subscription Price").

 

For each two new Ordinary Shares purchased under the Subscription, the investor will receive one warrant to subscribe for new Ordinary Shares at an exercise price of 504 pence per Ordinary Share for a period of five years, conditional on either the market capitalisation of the Company exceeding US$500 million for a period of three consecutive trading days or a future funding round being concluded with a post-money valuation of US$500 million or greater (the "Warrants"). A total of 70,742 Warrants will be issued under the Subscription, once the funds are received.

 

Once the US$2.0m from the Subscription announced today is received as per the above timetable, US$12m (out of the Board's target to raise circa US$25m) will have been raised under the current funding round.

 

Further announcements will be made by the Company as and when appropriate in relation to amongst other matters, the Subscription and the receipt of funds from the Gulf-based investor.

Richard Shearer, Tintra CEO, said, "We continue to make headway in the funding round, both with conversations that have been ongoing for some time and with new conversations starting. We have strategically now broadened the geographic footprint of our funding discussions in line with both macro-economic realities and the advancing nature of the Puerto Rico IFE application. As such we are now for the first time in funding discussions in Latin America over the past few weeks from where we hope the next amounts to come from.

We continue each week to make advances, and in some cases breakthroughs, in the regulation, tech and culture verticals.

We have this week had our Head of African Strategy, Constantine Chikosi in the offices in London all week where we have made massive headway in Tintra's strategy for the African continent. Having an ex-World Banker leading that for the past month or so has changed the cadence of the African roll out unrecognisably and we will be adding in funding discussions on that continent over the coming few weeks.

The reality is that there remains a lot of capital globally looking to deploy into Artificial Intelligence. That has not changed, if anything the sector is becoming more desirable not less and whilst it's not as fast as I'd like post the downturn we have enough visibility on the discussions to feel comfortable that we will continue to close out this round.

To the point where, learning lessons learned in the last few months that things now take longer, we've also recently begun early-stage conversations with two sovereign funds about what the next round might look like and what they'd need to see us have delivered and/or have operational before we'd meet their criteria."

Update on Funding Round & Total Voting Rights

 

Further to the Company's announcement on 30 January 2023, the Company is pleased to confirm that 684,594 new Ordinary Shares have been issued in certificated form to Ares FZE LLC. Accordingly, application has been made to London Stock Exchange plc for 684,594 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is currently anticipated that Admission will become effective and that dealings in the new Ordinary Shares will commence on AIM at 8.00 a.m. on or around 16 March 2023.

 

On Admission, the Company will have 16,138,263 Ordinary Shares in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of Ordinary Shares in issue and voting rights will be 16,138,263 and this figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

On Admission, Ares FZE LLC will hold the equivalent of 4.24% of the Ordinary Shares in issue.

 

For further information, contact:

 

Tintra PLC

(Communications Head)

Hannah Haffield

h.haffield@tintra.com

Website www.tintra.com

020 3795 0421

 

Allenby Capital Limited

(Nomad, Financial Adviser & Broker)

John Depasquale / Nick Harriss / Vivek Bhardwaj

 

020 3328 5656

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEAEDEFAFDEFA
Date   Source Headline
8th Jan 20247:00 amRNSCancellation - Tintra plc
4th Jan 20241:21 pmRNSResult of General Meeting 4 January 2024
27th Dec 20237:00 amRNSUpdate on Proxy Votes Re: Special Resolutions
14th Dec 20236:01 pmRNSProxy votes relating to Special Resolutions
7th Dec 20232:20 pmRNSGeneral Meeting & Matched Bargain Facility
6th Dec 202311:02 amRNSResignation of Nominated Adviser and Broker
6th Dec 20239:04 amRNSCirc re. General Meeting
28th Nov 20236:00 pmRNSIntention to Seek Cancellation from Trading on AIM
6th Nov 20237:24 amRNSRule 2.8 and Proposed Tender Offer
6th Nov 20237:00 amRNSTender Offer replaces Possible Offer & AIM delist
2nd Nov 20234:14 pmRNSResult of Adjourned AGM and GM
31st Oct 20236:16 pmRNSHalf-year Report to 31 July 2023
20th Oct 202311:54 amRNSPCA/PDMR Dealing & Holding in Company
19th Oct 202310:44 amRNSForm 8.3 - TINTRA PLC Amendment
17th Oct 20236:00 pmRNSNotice of Reconvened AGM & Notice of GM
11th Oct 20233:37 pmRNSForm 8.3 - TINTRA PLC
6th Oct 20234:06 pmRNSForm 8 (DD) - Offeree Concert Party - Tintra plc
6th Oct 20239:35 amRNSForm 8 (DD) - Offeree Concert Party - Tintra plc
5th Oct 20231:35 pmRNSForm 8.3 - TINTRA PLC
5th Oct 202310:32 amRNSForm 8 (DD) - Offeree Concert Party - Tintra plc
5th Oct 20237:00 amRNSExtension of PUSU deadline pursuant to Rule 2.6(c)
3rd Oct 202310:15 amRNSResumption of Trading on AIM
3rd Oct 202310:15 amRNSRestoration - Tintra plc
2nd Oct 20233:30 pmRNSAnnual Financial Report for the year to 31 Jan 23
2nd Oct 20231:00 pmRNSForm 8.3 - Tintra plc - Empire Global
29th Sep 202311:33 amRNSForm 8.3 - Tintra PLC
29th Sep 202311:03 amRNSForm 8 (DD) - Offeree Concert Party - Tintra PLC
29th Sep 202310:46 amRNSForm 8.3 - Offeree - Updated
29th Sep 202310:45 amRNSDirector/PDMR Shareholding
27th Sep 202311:30 amRNSForm 8.3 - Tintra plc - Crescent Moon Ventures
26th Sep 20237:00 amRNSForm 8 (OPD) Offeror - Tintra PLC
25th Sep 20232:30 pmRNSTechnology Partnership Agreement
25th Sep 20232:26 pmRNSForm 8.3 - Tintra plc - A Stuart-Bamford
25th Sep 20232:15 pmRNSForm 8.3 - Tintra plc - P Jackson
21st Sep 20236:23 pmRNSForm 8 (OPD) - Tintra Plc
14th Sep 20231:35 pmRNSForm 8.3 - Tintra PLC
7th Sep 20231:30 pmRNSStatement re Possible Offer
1st Sep 202311:30 amRNSFurther re Audited Accounts to 31 Jan 2023
31st Aug 20235:00 pmRNSRevised Financing Arrangement
10th Aug 20237:00 amRNSPlacement Facility Update
1st Aug 20237:30 amRNSSuspension - Tintra plc
31st Jul 20235:30 pmRNSConversion of Securities
31st Jul 202312:00 pmRNSResult of AGM
31st Jul 20239:00 amRNS12 Month Unaudited Results to 31 January 2023
19th Jul 20232:00 pmRNSExpected delay in publication of Annual Report
11th Jul 20237:00 amRNSSubscription Update
7th Jul 20237:00 amRNSNotice of AGM and Directorate & Management Change
5th Jul 20237:00 amRNSRepayment & Termination of Placement Facility
30th Jun 20239:00 amRNSDirectorate & Management Change
9th Jun 20233:43 pmRNSBusiness Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.